4 of 6
Calming chronic pain

While many of last year's business plan competitors have found the venture capital market tough to crack, fourth-place winner MicroTransponder has triumphed. Late last month the medical-device startup closed a $2.2 million funding round.

Why are investors lining up? The founders developed a device that allows doctors to treat chronic pain and other neurological maladies through wireless signals. In the past year the company has grown from four to 10 full-time employees and plans to finalize its prototype this spring. The startup will complete pilot trials by the end of the year and then hopes to sell its technology to a huge medical device company such as Boston Scientific or Medtronic.

NEXT: Aiming for investors' hearts - and patients'

LAST UPDATE: Apr 15 2009 | 9:06 AM ET
Sponsored by
Meet the competitors Dozens of aspiring entrepreneurs will vie for a share of $800,000 in seed money at this month's Rice Business Plan Competition. More
7 business plan superstars After winning competitions with their business plans, these 7 ventures turned their paper visions into thriving companies. More
10 steps to catch VC cash Follow our 10-point guide to landing the right investors. More

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.